Catalyst overview
Research summary
This catalyst tracks a Phase 1b data readout for AG-181 in Phenylketonuria. The expected timing is based on the latest available company guidance and may change.
07/30/26:- AG-181 Ph1b dosed first PKU patient; data expected H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.